ENTIS Position Statement; COVID-19 vaccines in pregnancy and lactation

The ENTIS Board and Scientific Committee are pleased to announce the official position of the ENTIS organisation on the use of COVID-19 vaccines in pregnant and lactating women. In summary, ENTIS holds the position that vaccination is the currently the most effective measure to reduce the risks associated with COVID-19 disease in pregnant women. Current safety data are reassuring, and […]

» Read more

New members of the ENTIS Scientific Committee

The ENTIS Board and Scientific Committee are happy to announce that Professor Per Damkier (MD, PhD) has been elected as the new chair of the ENTIS Scientific Committee. The Board and Scientific Committee are also pleased to announce that two new members will be joining the committee to replace two retiring members (Professor Hedvig Nordeng and Dr Yusuf Cem Kaplan, […]

» Read more

Save the Date: Virtual Scientific Meeting – Tuesday 20th April and 27th May

The ENTIS Board and  Scientific Committee are pleased to announce the 2021 Scientific Meeting which will take place virtually on two dates in April and May. Please mark your diaries with the following dates and times: Tuesday 20th April 16:00-18:00 CEST Thursday 27th May 16:00-18:00 CEST These online events will include oral presentations along with plenary sessions about COVID-19 vaccination in pregnancy […]

» Read more

Pregnant and breastfeeding women’s mental health status during the first wave of the COVID-19 pandemic

Collaborators from ENTIS and affiliated organisations have published the results of a web-based survey investigating how the first wave of the COVID-19 pandemic impacted the mental health status of pregnant and breastfeeding women. This multinational survey was promoted in Ireland, Norway, Switzerland, the Netherlands, and the UK between 16 June and 14 July 2020, and identified high levels of depressive […]

» Read more

Should ondansetron be avoided in pregnancy?

Two short debate papers have been published in the British Journal of Obstetrics and Gynaecology discussing the safety of ondansetron use in early pregnancy. Professor Per Damkier in collaboration with the ENTIS Scientific Committee led the argument against avoiding ondansetron use in pregnancy, while Professor Russell Kirby from the College of Public Health, University of South Florida led the argument […]

» Read more

Changes to the ENTIS board

The ENTIS board is happy to announce that Maria Ellfolk from Helsinki TIS has been elected as a new representative.  This is the first time ENTIS have applied an anonymous online election process. We congratulate and welcome Maria who we believe is an excellent choice, and look forward to working together with her in the future. We would also like […]

» Read more
1 2 3